Chinook Therapeutics Inc.

Q2 2019 13F Holders

Symbol
KDNY
CUSIP
00739L101
Type
Equity
Class
COM
Num filings
103
Total reported value, excl. options
$54.1 M
Manager Report Date Value ($000) Shares Option Type